Comprehension of cancer risk one and 12 months after predictive genetic testing for hereditary non-polyposis colorectal cancer
Authors:
- Ari HaukkalaAHAri Haukkala
- Jukka-Pekka MecklinJMJukka-Pekka Mecklin
- Antti UutelaAUAntti Uutela
- Helena KääriäinenHKHelena Kääriäinen
Open Access
- 1 November 2001
- journal article
- Published by BMJ in Journal of Medical Genetics
- Vol. 38 (11) , 787-792
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Prophylactic Surgery Decisions and Surveillance Practices One Year Following BRCA1/2 TestingPreventive Medicine, 2000
- Response to genetic counseling and testing for the APC I1307K mutationAmerican Journal of Medical Genetics, 2000
- Predictive genetic testing for hereditary non-polyposis colorectal cancer: Uptake and long-term satisfactionInternational Journal of Cancer, 2000
- Genetic Testing in Families With Hereditary Nonpolyposis Colon CancerJAMA, 1999
- Cancer risk in mutation carriers of DNA-mismatch-repair genesInternational Journal of Cancer, 1999
- A cost-effectiveness analysis of colorectal screening for hereditary nonpolyposis colorectal carcinoma gene carriersCancer, 1998
- Mutation sharing, predominant involvement of the MLH1 gene and description of four novel mutations in hereditary nonpolyposis colorectal cancerHuman Mutation, 1998
- Risk perception after CF carrier testing and impact of the test result on reproductive decision makingAmerican Journal of Medical Genetics, 1997
- On attitudes and appreciation 6 months after predictive DNA testing for huntington disease in the Dutch programAmerican Journal of Medical Genetics, 1993
- Predictive testing for Huntington disease in Canada: Adverse effects and unexpected results in those receiving a decreased riskAmerican Journal of Medical Genetics, 1992